| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/19/2011 | CN101100675B BIV indication cell line using enhanced green fluorescence protein as reporting gene |
| 01/18/2011 | USRE42046 granular starch hydrolyzing comprising isolated acid stable alpha amylase and glucoamylase; from Trichoderma |
| 01/18/2011 | US7872184 Plants and seeds of hybrid corn variety CH955795 |
| 01/18/2011 | US7872183 Plants and seeds of corn variety CV605722 |
| 01/18/2011 | US7872182 Plants and seeds of hybrid corn variety CH951965 |
| 01/18/2011 | US7872181 Plants and seeds of corn variety CV135273 |
| 01/18/2011 | US7872180 Maize variety PHHEB |
| 01/18/2011 | US7872179 Maize variety PHHKE |
| 01/18/2011 | US7872178 Plants and seeds of hybrid corn variety CH929154 |
| 01/18/2011 | US7872177 Plants and seeds of hybrid corn variety CH151527 |
| 01/18/2011 | US7872176 Soybean variety RJS54001 |
| 01/18/2011 | US7872175 Soybean variety XB05L09 |
| 01/18/2011 | US7872174 Soybean variety 4647672 |
| 01/18/2011 | US7872173 Plants having increased yield and method for making the same |
| 01/18/2011 | US7872172 by introducing into a plant a nucleic acid encoding a cyclin D3 protein under the control of a promoter capable of preferentially expressing the nucleic acid in shoots |
| 01/18/2011 | US7872171 Quantitative trait loci associated with soybean cyst nematode resistance and uses thereof |
| 01/18/2011 | US7872170 Using primer amplification to identify presence of polymorphism which confers system II resistance to parasitic herbs; propagating disease resistant plants |
| 01/18/2011 | US7872118 siRNA and methods of manufacture |
| 01/18/2011 | US7872117 c-met siRNA adenovirus vectors inhibit cancer cell growth, invasion and tumorigenicity |
| 01/18/2011 | US7872115 hybrid polynucleotide comprising a S.cerevisiae YIL066W-A Promoter operably linked to a reporter; used in assays to identify novel anti-fungal and anti-cancer substances; drug screening |
| 01/18/2011 | US7872114 Or Escherichia coli (E. coli) heat labile toxin where in the amino acid sequence, serine-63 and arginine-192 are replaced by another amino acid; vaccines against cholera and enterotoxigenic strain of E. coli |
| 01/18/2011 | US7872112 comprising rat apoptosis-specific eucaryotic initiation Factor-5A (eIF-5A),deoxyhypusine synthase (DHS) nucleic acids and polypeptides; human cytomegalovirus immediate-early promoter/enhancer |
| 01/18/2011 | US7872110 Deimmunized monoclonal antibodies for protection against HIV exposure and treatment of HIV infection |
| 01/18/2011 | US7872107 Interleukin-12p40 variants with improved stability |
| 01/18/2011 | US7872096 ligating recombinant intein domains to a linear synthetic protein to form a compound D1-X(n)-D2, where D1 and D2 are catalytic domains of an intein and X is a protein; cell-free; producing small cyclic peptides containing non-genetically encodable amino acids; for drugs |
| 01/18/2011 | US7872094 using polypeptide comprising a membrane translocation domain and a NF- kappa B Essential Modulator (NEMO) binding sequence; comprising a NEMO binding domain (NBD) |
| 01/18/2011 | US7871986 provides a prostate specific antigen oligo-epitope peptide (PSA-OP) that is useful as an immunogen in the prevention or treatment of prostatic cancer and in the inhibition of prostatic cancer cells and in the establishment and characterization of PSA-specific cytotoxic T-cell lines |
| 01/18/2011 | US7871985 Compositions and methods for inhibiting expression of factor VII gene |
| 01/18/2011 | US7871984 Suppress the immunoreactivity of a CpG motif and preventing and treating immune-mediated diseases such as arthritis |
| 01/18/2011 | US7871983 For therapy and prophylaxis of ischemic diseases, inflammatory diseases, autoimmune diseases, cancer metastasis and invasion, and cachexia |
| 01/18/2011 | US7871827 Methods and devices for removal of organic molecules from biological mixtures using anion exchange |
| 01/18/2011 | US7871819 recombinant vector comprising a sequence encoding a heterologous polypeptide inserted between E4 and E3 transcription units of an ovine adenovirus genome; directing expression of a coding sequence in a cell; cancer |
| 01/18/2011 | US7871818 Membrane active polymers |
| 01/18/2011 | US7871817 in vitro method for producing a T-cell expressing a T-cell receptor (TCR); mediate an oncogen-specific T-cell response |
| 01/18/2011 | US7871816 for preparing a vaccine which contains one or more than two genes among pgs B, pgs C and pgs A encoding poly- gamma -glutamate synthetase complex and genes selected from human papilloma virus (HPV) E6 and HPV E7 antigen protein associated with tumor induction; genital wash |
| 01/18/2011 | US7871815 producing a protein by cloning an open reading frame encoding a protein into the nucleic acid sequence of SEQ ID 151, introducing the resulting nucleic acid sequence into a host cell and exposing the host cell to rhamnose, thereby inducing expression of the protein |
| 01/18/2011 | US7871814 Recombinant bicistronic flaviviruses and methods of use thereof |
| 01/18/2011 | US7871806 Asparaginases |
| 01/18/2011 | US7871804 Method for producing polyunsaturated long-chain fatty acids in transgenic organisms |
| 01/18/2011 | US7871803 from plankton Metridia pacifica; blue luminescence |
| 01/18/2011 | US7871801 L-amino acid-producing bacterium and a method for producing L-amino acids |
| 01/18/2011 | US7871798 Mammalian cells that express VEGF-D polypeptides |
| 01/18/2011 | US7871797 proteolysis; recombinant vectors; transformants |
| 01/18/2011 | US7871796 Isolation of binding proteins with high affinity to ligands |
| 01/18/2011 | US7871786 Isolated nucleic acid encoding GEF-H1b polypeptide (Guanine nucleotide exchange factors); diagnosing abnormal cell proliferation and drug screening; measuring phosphorylation by p-21 activated kinase; antitumor agents, anticancer agents |
| 01/18/2011 | US7871779 Molecular identification of Aspergillus species |
| 01/18/2011 | US7871768 detecting point mutations, deletions |
| 01/18/2011 | US7871767 Polymorphisms in the human gene for cytochrome P450 polypeptide 2C8 and their use in diagnostic applications |
| 01/18/2011 | US7871763 gene expression; probes, primers, antibodies |
| 01/18/2011 | US7871625 hepatitis C virus (HCV); immunoassay; recombinant vectors, host cells; kits |
| 01/18/2011 | US7871614 Gold-binding protein and use thereof |
| 01/18/2011 | US7871604 microbial cells (avirulent Salmonella) comprising Environmentally Limited Viability System; cell is viable in permissive environment and non-viable or temporarily viable in non-permissive environment; antigen for expression of gamete-specific antigens to induce immune responses to block fertility |
| 01/18/2011 | CA2637795C Antagonists of interleukin-15 |
| 01/18/2011 | CA2594294C Plant-optimized genes encoding pesticidal toxins |
| 01/18/2011 | CA2511128C Late-pcr |
| 01/18/2011 | CA2496880C Methods for developing conifer somatic embryos |
| 01/18/2011 | CA2479045C Amplification-hybridisation method for detecting and typing human papillomavirus |
| 01/18/2011 | CA2455145C Pregnancy-related serine protease |
| 01/18/2011 | CA2427347C Method and means for producing barley yellow dwarf virus resistant cereal plants |
| 01/18/2011 | CA2418977C Gene delivery vectors with cell type specificity for primary human chondrocytes |
| 01/18/2011 | CA2400666C Method for preparing functionalised polyalkylenimines, composition containing same and uses thereof |
| 01/18/2011 | CA2385444C Humanin, a polypeptide suppressing neuronal death |
| 01/18/2011 | CA2383737C Muc-1 derived peptides |
| 01/18/2011 | CA2380537C An oncolytic adenovirus |
| 01/18/2011 | CA2360073C Probes and primers for detecting prostate specific antigen (psa) in a biological sample |
| 01/18/2011 | CA2331263C A method of producing cells with a desired property by recursive sequence recombination |
| 01/18/2011 | CA2319754C Glycosyltransferase and dna encoding the same |
| 01/18/2011 | CA2301204C Sugarcane bacilliform virus promoter |
| 01/18/2011 | CA2260858C Polynucleotide vaccine formulation against pathologies of the horse |
| 01/18/2011 | CA2192195C Modification of starch content in plants |
| 01/18/2011 | CA2191053C A fusion protein comprising a furin derivative or a derivative of a furin analogue and a heterlogous sequence |
| 01/18/2011 | CA2156976C Genetic sequences encoding glucocorticoid dehydrogenases and uses therefor |
| 01/13/2011 | WO2011006165A2 Detecting multinucleotide repeats |
| 01/13/2011 | WO2011006161A2 Compositions and methods for diagnosing and treating macular degeneration |
| 01/13/2011 | WO2011006145A2 Compositions and methods for mammalian genetics and uses thereof |
| 01/13/2011 | WO2011006133A2 Bioengineered silk protein-based nucleic acid delivery systems |
| 01/13/2011 | WO2011006126A2 Engineered microorganisms with enhanced fermentation activity |
| 01/13/2011 | WO2011006119A2 Gene expression profiles associated with chronic allograft nephropathy |
| 01/13/2011 | WO2011005968A1 Codon-optimized factor vi i i variants and synthetic liver-specific promoter |
| 01/13/2011 | WO2011005867A1 Polypeptides having cellulolytic enhancing activity activity and polynucleotides encoding same |
| 01/13/2011 | WO2011005861A1 Oligonucleotide end caps |
| 01/13/2011 | WO2011005793A1 Cell-based bioprocessing |
| 01/13/2011 | WO2011005769A1 Methods for preparing vesicles and formulations produced therefrom |
| 01/13/2011 | WO2011005765A1 Bioprocessing |
| 01/13/2011 | WO2011005598A1 Compositions and methods for the rapid biosynthesis and in vivo screening of biologically relevant peptides |
| 01/13/2011 | WO2011005593A2 Schistosomiasis vaccine compositions and methods of use |
| 01/13/2011 | WO2011005580A2 Adult animals generated from induced pluripotent cells |
| 01/13/2011 | WO2011005554A2 Recombinant ethanologenic bacteria |
| 01/13/2011 | WO2011005527A2 Ketoreductase-mediated stereoselective route to alpha chloroalcohols |
| 01/13/2011 | WO2011005523A2 Galectin-immunoglobulin chimeric molecules |
| 01/13/2011 | WO2011005496A2 Islet1 (isl1) and hearing loss |
| 01/13/2011 | WO2011005221A1 Methods of identifying a pair of binding partners |
| 01/13/2011 | WO2011005094A1 High throughput method and system for in vivo screening |
| 01/13/2011 | WO2011005090A1 Method for increasing the resistance of a plant or a part thereof to a pathogen, method for screening the resistance of a plant or part thereof to a pathogen, and use thereof |
| 01/13/2011 | WO2011004994A2 A novel genome walking method for cloning of unknown dna sequences adjacent to known sequence |
| 01/13/2011 | WO2011004962A2 Method for producing l-lysine using corynebacterium sp. that has obtained the activity of glyceraldehyde-3-phosphate dehydrogenase derived from an alien species |
| 01/13/2011 | WO2011004957A2 Probe for detecting the resistance of mycobacterium tuberculosis to drugs, and kit for same |
| 01/13/2011 | WO2011004896A1 Method for detection or analysis of target sequence in genomic dna |
| 01/13/2011 | WO2011004847A1 NOVEL HUMANIZED ANTI-HUMAN α9-INTEGRIN ANTIBODY |
| 01/13/2011 | WO2011004837A1 Antibody having anti-cancer activity |